Publications by authors named "Jose Omar Barreto-Rodriguez"
Article Synopsis
- A study was conducted to analyze the impact of critical COVID-19 on patients with pre-existing interstitial lung disease (ILD) compared to those without lung disease.
- Out of 123 participants, the study found that patients with ILD had a higher mortality rate during hospitalization (63%) compared to controls (33%).
- Factors such as higher body mass index (BMI) and fewer days of hospitalization were observed in patients with ILD who did not survive, indicating more severe health complications.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a global health threat with the potential to cause severe disease manifestations in the lungs. Although COVID-19 has been extensively characterized clinically, the factors distinguishing SARS-CoV-2 from other respiratory viruses are unknown. Here, we compared the clinical, histopathological, and immunological characteristics of patients with COVID-19 and pandemic influenza A(H1N1).
View Article and Find Full Text PDFObjective: We sought to determine the accuracy of the LOW-HARM score (Lymphopenia, Oxygen saturation, White blood cells, Hypertension, Age, Renal injury, and Myocardial injury) for predicting death from coronavirus disease 2019) COVID-19.
Methods: We derived the score as a concatenated Fagan's nomogram for Bayes theorem using data from published cohorts of patients with COVID-19. We validated the score on 400 consecutive COVID-19 hospital admissions (200 deaths and 200 survivors) from 12 hospitals in Mexico.